Yıl: 2019 Cilt: 25 Sayı: 1 Sayfa Aralığı: 12 - 18 Metin Dili: İngilizce DOI: DOI: 10.5152/EurJTher.2018.476 İndeks Tarihi: 26-11-2020

Evaluation of Hypertension-Related Mortality in Turkey (2000–2014)

Öz:
Objective: Hypertension continues to be the leading risk factor for cardiovascular disease (CVD) and mortality worldwide. The purpose of the present study was to analyze the long-term trends of hypertension mortality in Turkey between 2000 and 2014 (for males and females). Methods: Analyses were based on hypertension mortality data obtained from the Turkish Statistical Institute death database. Age-standardized mortality rates were calculated using direct standardization for each calendar year. We estimated the age-adjusted linear trend for annual percent change and average annual percent change (AAPC) with the corresponding 95% confidence interval (CI) using the joinpoint regression analysis. Furthermore, we conducted an age–period–cohort analysis to quantify recent time trends and to evaluate the significance of cohort and period effects. Results: During the study period, a significant upward trend in the mortality of hypertension in Turkey is observed (AAPC=2.7%, 95% CI 1.9%–3.4%). The trend of hypertension mortality has increased in both males (AAPC=7.4%, 95% CI 3.0%–11.9%) and females (AAPC=8.7%, 95% CI 4.1%–13.5%). We found that the net drift rateswere 2.1% (95% CI 0.6%–3.6%) per year for males and 2.0% (95% CI 0.4%–3.7%) per year for females. According to longitudinal age curves, the mortality of hypertension increased with age in both males and females. The period and cohort effects are highly significant in both males and females. Conclusion: Hypertension is one of the leading causes of mortality causing CVD. Knowing the risk factors and preventive methods could help to reduce hypertension-related mortalities.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • World HealthOrganization. A globalbrief on hypertension:silent killer, global publichealthcrisis: World HealthDay 2013 (cited 2016 May 5): Available from: URL: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/
  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of diseaseandinjuryattributableto 67 risk factorsand risk factorclusters in 21 regions, 19902010: a systematicanalysisforthe Global Burden of DiseaseStudy 2010. Lancet 2012; 380: 2224-60.
  • Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in ruraland urban communities in high-, middle-, andlow-income countries. JAMA 2013; 310: 959-68.
  • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
  • Hussain MA, Al Mamun A, Reid C, Huxley RR. Prevalence, awareness, treatmentandcontrol of hypertension in Indonesianadultsaged≥ 40 Years: FindingsfromtheIndonesiaFamily Life Survey (IFLS). PloS ONE 2016; 11: e0160922.
  • World HealthOrganization. Global statusreport on noncommunicablediseases 2010. Geneva, 2011. (cited 2016 May 20) Available from: URL: http://www.who.int/nmh/publications/ncd_report_full_ en.pdf
  • World Health Organization. Global Health Observatory (GHO) dataraised blood presurre, situation and trends. 2008. (cited 2016 June 25) Available from: URL: http://www.who.int/gho/ncd/risk_ factors/blood_pressure_prevalence_text/en/
  • Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon hypertension study. J Public Health (Oxf.) 2008; 31: 47-58.
  • Dogan N, Toprak D, Demir S. Hypertension prevalence and risk factors among adult population in Afyonkarahisar region: a cross-sectional research. Anadolu Kardiyol Derg 2012; 12: 47-52.
  • 10. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80.
  • 11. Onat A, Karakoyun S, Akbaş T, Karadeniz FÖ, Karadeniz Y, Çakır H, et al. Turkish adult risk factor survey 2014: Overall mortality and coronary disease incidence in Turkey’s geographic regions. Turk Kardiyol Dern Arş 2015; 43: 326-32.
  • 12. Altun B, Süleymanlar G, Utaş C, Arınsoy T, Ateş K, Ecder T, et al. Prevalence, awareness, treatmentandcontrol of hypertension in adultswithchronickidneydisease in Turkey: resultsfromthe CREDIT study. Kidneyand Blood Pressure Research 2012; 36: 36-46.
  • 13. Sengul S, Erdem Y, Batuman V, Erturk S. Hypertension and chronic kidney disease in Turkey. Kidney Int Suppl (2011) 2013; 3: 308-11.
  • 14. O’Brien R. Age-period-cohort models: Approaches and analyses with aggregate data. Eugene: CRC Press; 2014.
  • 15. Mason WM, Wolfinger NH. Cohortanalysis. California Center forPopulation Research. 2001. (cited 2015 June 25) Available from: URL: https://escholarship.org/uc/item/8wc8v8cv
  • 16. Yang Y, Land KC. Age-period-cohortanalysis: New models, methods, andempiricalapplications. New York: CRC Press; 2013.
  • 17. Turkish Statistical Institutedeathdatabase. (cited 2015 October 5) Available from: URL: http://www.turkstat.gov.tr.
  • 18. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: World Health Organization. 2001; 31: 1-4.
  • 19. NationalCancerInstitutes, Surveillance Research Program, 2013. (Available from: http://surveillance.cancer.gov/joinpoint)/
  • 20. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for join point regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
  • 21. Rosenberg PS, Anderson WF. Age-period-cohortmodels in cancersurveillanceresearch: readyfor prime time? Cancer Epidemiol Biomarkers Prev 2011; 20: 1263-8.
  • 22. Rosenberg PS, Check DP, Anderson WF. A web tool forage–periodcohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 2014; 23: 2296-302.
  • 23. Regulation on sugar and salt in public institutions; Circularnumber: 92148377/323; 2014/4. Available from: https://dosyasb.saglik.gov. tr/Eklenti/407,sekertuzkullanimihakkindagenelgepdf.pdf?0 (accessed date: 30.07.2018)
  • 24. Kung HC, Xu J. Hypertension-related mortality in the United States, 2000-2013. NCHS Data Brief 2015; 1-8.
  • 25. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens 2016; 34: 1208-17.
  • 26. United Nations, Department of EconomicandSocialAffairs, PopulationDivision (2011). World PopulationProspects: The 2010 Revision, Volume I: ComprehensiveTables. ST/ESA/SER.A/313, 2011.
  • 27. Life Expectancy, WHO. Available from: http://www.who.int/gho/ mortality_burden_disease/life_tables/situation_trends/en/ (Accessed date: 30.07.2018)
  • 28. Erdem Y, Arici M, Altun B, Turgan C, Sindel S, Erbay B, et al. The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press 2010; 19: 313-8.
  • 29. Akpolat T, Kadı R, Utaş C. Hypertension, salt, and bread. Am J Kidney Dis 2009; 53: 1103.
APA Doğan N, Toprak D, DOĞAN İ (2019). Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). , 12 - 18. DOI: 10.5152/EurJTher.2018.476
Chicago Doğan Nurhan,Toprak Dilek,DOĞAN İsmet Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). (2019): 12 - 18. DOI: 10.5152/EurJTher.2018.476
MLA Doğan Nurhan,Toprak Dilek,DOĞAN İsmet Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). , 2019, ss.12 - 18. DOI: 10.5152/EurJTher.2018.476
AMA Doğan N,Toprak D,DOĞAN İ Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). . 2019; 12 - 18. DOI: 10.5152/EurJTher.2018.476
Vancouver Doğan N,Toprak D,DOĞAN İ Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). . 2019; 12 - 18. DOI: 10.5152/EurJTher.2018.476
IEEE Doğan N,Toprak D,DOĞAN İ "Evaluation of Hypertension-Related Mortality in Turkey (2000–2014)." , ss.12 - 18, 2019. DOI: 10.5152/EurJTher.2018.476
ISNAD Doğan, Nurhan vd. "Evaluation of Hypertension-Related Mortality in Turkey (2000–2014)". (2019), 12-18. https://doi.org/DOI: 10.5152/EurJTher.2018.476
APA Doğan N, Toprak D, DOĞAN İ (2019). Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). European Journal of Therapeutics, 25(1), 12 - 18. DOI: 10.5152/EurJTher.2018.476
Chicago Doğan Nurhan,Toprak Dilek,DOĞAN İsmet Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). European Journal of Therapeutics 25, no.1 (2019): 12 - 18. DOI: 10.5152/EurJTher.2018.476
MLA Doğan Nurhan,Toprak Dilek,DOĞAN İsmet Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). European Journal of Therapeutics, vol.25, no.1, 2019, ss.12 - 18. DOI: 10.5152/EurJTher.2018.476
AMA Doğan N,Toprak D,DOĞAN İ Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). European Journal of Therapeutics. 2019; 25(1): 12 - 18. DOI: 10.5152/EurJTher.2018.476
Vancouver Doğan N,Toprak D,DOĞAN İ Evaluation of Hypertension-Related Mortality in Turkey (2000–2014). European Journal of Therapeutics. 2019; 25(1): 12 - 18. DOI: 10.5152/EurJTher.2018.476
IEEE Doğan N,Toprak D,DOĞAN İ "Evaluation of Hypertension-Related Mortality in Turkey (2000–2014)." European Journal of Therapeutics, 25, ss.12 - 18, 2019. DOI: 10.5152/EurJTher.2018.476
ISNAD Doğan, Nurhan vd. "Evaluation of Hypertension-Related Mortality in Turkey (2000–2014)". European Journal of Therapeutics 25/1 (2019), 12-18. https://doi.org/DOI: 10.5152/EurJTher.2018.476